All Stories

  1. Regorafenib for treatment of hepatocellular carcinoma
  2. To TACE or not to TACE: that is the question
  3. Risk scores for hepatocellular carcinoma in chronic hepatitis B
  4. Screening for liver cancer: Another piece of the puzzle?